Weight gain and diabetes  with “second-generation” antipsychotic drugs

Andrew Firestone

Correspondence: afire@tpg.com.au

1. American Diabetes Association, American Psychiatric Association, American Association of Clinical Endocrinologists, North American Association for the Study of Obesity. Consensus development conference on antipsychotic drugs and obesity and diabetes. Diabetes Care 2004; 27: 596-601.
2. Graham KA, Perkins DO, Edwards LJ, et al. Effect of olanzapine on body composition and energy expenditure in adults with first-episode psychosis. Am J Psychiatry 2005; 162: 118-123.
3. Holzer L, Paiva G, Halfon O. Quetiapine-induced weight gain and escitalopram. Am J Psychiatry 2005; 162: 201-202.
4. Lambert TJR, Chapman LH, on behalf of the Consensus Working Group. Diabetes, psychotic disorders and antipsychotic therapy: a consensus statement. Med J Aust 2004; 181: 544-548. <MJA full text>
5. Firestone A. Diabetes, psychotic disorders and antipsychotic therapy: a consensus statement [letter]. Med J Aust 2004; 182: 310. <MJA full text>

Online responses are no longer available. Please refer to our instructions for authors page for more information.